The essential menopause curriculum for healthcare professionals: A European Menopause and Andropause Society (EMAS) position statement

The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030

(2021) Birgit Vogel et al.   LANCET

Topical estrogens and non-hormonal preparations for postmenopausal vulvovaginal atrophy: An EMAS clinical guide

(2021) Angelica Lindén Hirschberg et al.   MATURITAS

Neurokinin 3 Receptor Antagonists Compared With Serotonin Norepinephrine Reuptake Inhibitors for Non-Hormonal Treatment of Menopausal Hot Flushes: A Systematic Qualitative Review

(2021) Sara J. Menown et al.   ADVANCES IN THERAPY

Hormone therapy regimens for managing the menopause and premature ovarian insufficiency

(2021) Eleni Armeni et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Compounded Bioidentical Hormones

(2021) Nanette Santoro et al.   CLINICAL OBSTETRICS AND GYNECOLOGY

Global consensus recommendations on menopause in the workplace: A European Menopause and Andropause Society (EMAS) position statement

(2021) Margaret Rees et al.   MATURITAS

Risk of Subsequent Fractures in Postmenopausal Women After Nontraumatic vs Traumatic Fractures

(2021) Carolyn J. Crandall et al.   JAMA Internal Medicine

Effect of Fractional Carbon Dioxide Laser vs Sham Treatment on Symptom Severity in Women With Postmenopausal Vaginal Symptoms

(2021) Fiona G. Li et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Use of menopausal hormone therapy and risk of dementia: nested case-control studies using QResearch and CPRD databases

(2021) Yana Vinogradova et al.   BMJ-British Medical Journal

Menopausal Hormone Therapy and breast cancer risk: Individualization is the key to safety

(2020) Eleni Armeni et al.   MATURITAS

Association of Adverse Childhood Experiences with Menopausal Symptoms: Results from the Data Registry on Experiences of Aging, Menopause and Sexuality (DREAMS)

(2020) Ekta Kapoor et al.   MATURITAS

The Mediterranean diet and menopausal health: An EMAS position statement

(2020) Antonio Cano et al.   MATURITAS

Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists

(2020) Angela H E M Maas et al.   EUROPEAN HEART JOURNAL

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary

(2019) Donna K. Arnett et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

EMAS position statement: Predictors of premature and early natural menopause

(2019) Gita D. Mishra et al.   MATURITAS

Obesity, smoking, and risk of vasomotor menopausal symptoms: a pooled analysis of eight cohort studies

(2019) Debra J. Anderson et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Association of Premature Natural and Surgical Menopause With Incident Cardiovascular Disease

(2019) Michael C. Honigberg et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Menopause guideline appraisal and algorithm development for premature ovarian insufficiency

(2019) Ladan Yeganeh et al.   MATURITAS

Calcium in the prevention of postmenopausal osteoporosis: EMAS clinical guide

(2018) Antonio Cano et al.   MATURITAS

Symptoms of menopause — global prevalence, physiology and implications

(2018) Patrizia Monteleone et al.   Nature Reviews Endocrinology

Efficacy of intravaginal dehydroepiandrosterone (DHEA) for symptomatic women in the peri- or postmenopausal phase

(2018) Ulrike Sauer et al.   MATURITAS

IUGA committee opinion: laser-based vaginal devices for treatment of stress urinary incontinence, genitourinary syndrome of menopause, and vaginal laxity

(2018) S. Abbas Shobeiri et al.   INTERNATIONAL UROGYNECOLOGY JOURNAL

Hot flushes and night sweats symptom profiles over a 17-year period in mid-aged women: The role of hysterectomy with ovarian conservation

(2016) Louise F. Wilson et al.   MATURITAS

Maintaining postreproductive health: A care pathway from the European Menopause and Andropause Society (EMAS)

(2016) Eleni Armeni et al.   MATURITAS

Revised global consensus statement on menopausal hormone therapy

(2016) T.J. de Villiers et al.   MATURITAS

EMAS position statement: Non-hormonal management of menopausal vasomotor symptoms

(2015) Gesthimani Mintziori et al.   MATURITAS

The North American Menopause Society Statement on Continuing Use of Systemic Hormone Therapy After Age 65

(2015)   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Duration of Menopausal Vasomotor Symptoms Over the Menopause Transition

(2015) Nancy E. Avis et al.   JAMA Internal Medicine

EMAS position statement: Menopause for medical students

(2014) Janet Brockie et al.   MATURITAS